Lifeward Ltd (LFWD) Stock Analysis
Verdict: AVOID
Imminent dilution risk from an acute cash runway under two months outweighs commercial exoskeleton growth, making the stock uninvestable.
Investment score: 30/100
Analysis as of
Is Lifeward Ltd stock worth reviewing? AI model thesis
The model issues an AVOID verdict for Lifeward Ltd (LFWD) due to extreme liquidity risk, severe cash burn, and past equity dilution.
7-factor investment score
- Valuation: 30/100 (weight 20%)
- Financial Health: 10/100 (weight 15%)
- Technical Momentum: 40/100 (weight 15%)
- Earnings Quality: 20/100 (weight 15%)
- Insider Sentiment: 45/100 (weight 10%)
- Analyst Consensus: 65/100 (weight 10%)
- Risk-Adjusted Return: 15/100 (weight 15%)
Lifeward Ltd opportunities and risks
What speaks for LFWD
- CMS Medicare Reimbursement Expansion
What speaks against LFWD
- Acute Liquidity Exhaustion and Impending Equity Dilution
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| LFWD | n/a | 0.5x | n/a | 36.0% | -141.3% | -152.0% |
| MBAI | 1.4x | 0.0x | 1.5x | 0.0% | 0.0% | -0.7% |
| ICCM | n/a | 1.3x | 0.4x | 36.1% | -427.7% | -326.3% |
| Peer median | 0.5x | 0.6x | 1.0x | 18.1% | -213.8% | -163.5% |
Frequently asked questions about Lifeward Ltd (LFWD)
Is LFWD stock a good investment?
The cached TradeMates AI model rates Lifeward Ltd as AVOID with an investment score of 30/100. The model issues an AVOID verdict for Lifeward Ltd (LFWD) due to extreme liquidity risk, severe cash burn, and past equity dilution. This is algorithmic model output, not personal investment advice.
Is LFWD stock a buy?
The TradeMates model verdict for LFWD is AVOID with an investment score of 30/100. Treat this as a model signal to review, not a personal buy recommendation.